NCOA5 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.184220E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.257600E-01
Normal-vs-Stage2
4.691800E-02
Normal-vs-Stage3
4.329900E-02
Normal-vs-Stage4
3.976200E-01
Stage1-vs-Stage2
2.450100E-02
Stage1-vs-Stage3
3.095700E-02
Stage1-vs-Stage4
4.105800E-01
Stage2-vs-Stage3
7.207600E-02
Stage2-vs-Stage4
6.643400E-01
Stage3-vs-Stage4
1.640020E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.394980E-01
Normal-vs-AfricanAmerican
2.243400E-01
Normal-vs-Asian
3.640400E-02
Caucasian-vs-AfricanAmerican
7.400000E-01
Caucasian-vs-Asian
2.714800E-01
AfricanAmerican-vs-Asian
1.583570E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.662370E-01
Normal-vs-Female
7.791500E-02
Male-vs-Female
7.731200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.872600E-01
Normal-vs-Age(41-60Yrs)
1.654980E-01
Normal-vs-Age(61-80Yrs)
1.125170E-01
Normal-vs-Age(81-100Yrs)
2.597400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.873840E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.230190E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.610400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.095760E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.793500E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.741600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.981400E-03
Normal-vs-Daily Drinker
1.618190E-01
Normal-vs-Weekly Drinker
1.235850E-01
Normal-vs-Occasional Drinker
1.891000E-01
Normal-vs-Social Drinker
3.269000E-01
Non Drinker-vs-Daily Drinker
1.661610E-01
Non Drinker-vs-Weekly Drinker
1.479180E-01
Non Drinker-vs-Occasional Drinker
7.239800E-02
Non Drinker-vs-Social Drinker
1.696420E-02
Daily Drinker-vs-Weekly Drinker
9.554200E-01
Daily Drinker-vs-Occasional Drinker
7.423200E-01
Daily Drinker-vs-Social Drinker
3.837600E-01
Weekly Drinker-vs-Occasional Drinker
7.888000E-01
Weekly Drinker-vs-Social Drinker
4.118400E-01
Occasional Drinker-vs-Social Drinker
5.683800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.854400E-01
Normal-vs-Grade 2
9.344800E-01
Normal-vs-Grade 3
9.396400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.172100E-02
Grade 1-vs-Grade 3
3.220500E-02
Grade 1-vs-Grade 4
6.854400E-01
Grade 2-vs-Grade 3
9.101800E-01
Grade 2-vs-Grade 4
9.344800E-01
Grade 3-vs-Grade 4
9.396400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.886000E-02
Normal-vs-NonDiabetic
1.496830E-01
Diabetic-vs-NonDiabetic
1.912810E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.216300E-02
Normal-vs-NoPancreatitis
1.257030E-01
Pancreatitis-vs-NoPancreatitis
2.551400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.210400E-01
Normal-vs-N1
5.824000E-02
N0-vs-N1
4.163600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.774800E-01
Normal-vs-TP53-NonMutant
6.378400E-01
TP53-Mutant-vs-TP53-NonMutant
1.212610E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
